NCBiotech News
We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.
Informing Innovation Conference Highlights Best Practices and Emerging Tools for Competitor and Product Research
pmagoon
Mon, 09/25/2023 - 13:27
On September 20, librarians, business development professionals, consultants, and students gathered at the North Carolina Biotechnology Center’s headquarters for its Informing Innovation 2023 conference.
Led by NCBiotech’s team, the day-long event provided attendees with the latest information on life sciences resources, search strategies, and copyright and research basics, among others. One hot topic was artificial intelligence (AI), which was top of mind for many attendees.
Durham Biopharma Company Kriya Acquires Gene Therapy Startup
ccapot
Mon, 09/18/2023 - 09:44
Kriya Therapeutics Inc., with dual headquarters in Durham and Palo Alto, Calif., has acquired a gene therapy startup that Kriya says will align with its approach to treating metabolic disease.
SBA Award Includes Funds for N.C. Ag Tech
aclark
Thu, 09/21/2023 - 15:33
The AgTech Innovation Alliance, an agricultural innovation network spearheaded by California-based nonprofit AgStart, has won a $150,000 Small Business Administration award that includes funds to boost North Carolina’s growing ag tech industry.
The North Carolina Biotechnology Center is participating as one of the alliance’s eight regional partners in receiving the award. NCBiotech - the only partner on the East Coast - will receive $10,000 over two years to support and promote innovation in crop science, animal health, food tech and precision agriculture.
Dignify Therapeutics Acquires Development Rights to Drug Candidate
ccapot
Wed, 09/13/2023 - 14:44
Dignify Therapeutics, a pharmaceutical and medical device development company in Research Triangle Park focused on restoring bowel and bladder control for elderly and neurologically impaired people, has added a new compound to its product pipeline.
The company has signed an in-licensing agreement with Aayam Therapeutics of San Jose, Calif., to develop Aayam’s ATX-003, a compound for on-demand defecation, and related proprietary molecules.
TARGAN celebrates new Raleigh headquarters
ccapot
Tue, 09/12/2023 - 14:47
TARGAN, Inc., a biotechnology systems and animal ag-tech company dedicated to improving agriculture through targeted applications of cutting-edge technologies, celebrated the official opening of its new Raleigh-based headquarters. TARGAN is the first company of its kind to be based in the Raleigh city limits.
The event not only marked a significant milestone for TARGAN but also brought attention to the region’s ongoing growth in the life sciences industry.
NC State’s Integrative Life Sciences Initiative and Building Support Future STEM Workforce
ccapot
Mon, 09/11/2023 - 10:49
North Carolina is home to some of the world’s leading life sciences companies, renowned research universities, and workforce development programs to support growing demand for STEM-trained employees. North Carolina State University’s latest project, the Integrative Sciences Initiative and Building, highlights a key strength of the state’s life sciences ecosystem: an understanding of the convergence of disciplines at the heart of life sciences innovation.
Levee Medical Raises Funds for Device to Improve Prostate Surgery Outcomes
ccapot
Fri, 09/08/2023 - 10:22
Durham-based Levee Medical has gotten additional financial backing for its first product to improve patient outcomes after prostate surgery.
The medical device startup announced that it has raised $4.3 million in oversubscribed funds that will be used to advance its Voro Urologic Scaffold. The investigational product is currently the only bioabsorbable implant to treat urinary incontinence following the surgical removal of the prostate gland.
Biofidelity Introduces Novel Lung Cancer Assay for Precision Medicine
ccapot
Thu, 09/07/2023 - 15:00
Biofidelity, a British genomic technology company with U.S. headquarters in Morrisville, has commercially launched a novel assay to guide the treatment of non-small cell lung cancer in U.S. patients.
The assay, called ASPYRE-Lung, simplifies and accelerates the detection of biomarkers for lung cancer, enabling clinicians to determine which treatment is best for each patient at a lower cost than current RNA and DNA sequencing tests, and in days instead of weeks, the company said in a news release.
Cell Microsystems Strengthens Suite of Products with Acquisition of West Coast Company
ccapot
Wed, 09/06/2023 - 11:52
Cell Microsystems recently announced its acquisition of Oakland, California-based Fluxion Biosciences, a developer of automated patch clamp technology and cell-based assay tools. The Durham-based company acquired Fluxion to complement its CellRaft technology for cell biology research.
Zoetis Opens New R&D Facility in Research Triangle
ccapot
Thu, 08/24/2023 - 14:49
Zoetis celebrated Thursday the official opening of its new 78,000-square-foot building in Durham dedicated to diagnostics and biodevices research and development (R&D) to meet the needs of veterinarians, livestock farmers and pet owners.
North Carolina Secretary of Commerce Machelle Baker Sanders and State Rep. Zack Hawkins joined Zoetis CEO Kristin Peck and other company officials and employees at the ribbon-cutting ceremony in front of the new facility. North Carolina State University’s College of Agriculture & Life Sciences also had representatives at the event.